Key facts
- Maui Imaging’s last known valuation is $133.0M (Jul 2025).
- It has raised $33.3M across 1 recorded rounds; the latest was Early Stage VC ($14.7M) in May 2025.
- Notable investors include US National Science Foundation, United States Department of War, Acertara Acoustic Laboratories, Elliot Pope, Richard Altinger.
- Maui Imaging has filed 1 Form D with the SEC, most recently Jul 2025 ($14.7M sold to 58 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Maui Imaging
Funding rounds
1 roundsAbout Maui Imaging
Manufacturer of a computed echo tomography platform designed to enable rapid and effective imaging of internal organs and structures through and beyond physical barriers. The company offers an FDA-cleared system protected by extensive patents, capable of generating large-scale datasets for real-time imaging by existing clinical personnel, enabling trauma, neurosurgery, and interventional radiology teams to improve diagnostic speed and accuracy.
- Sector
- Healthcare
- HQ
- Tucson, AZ, United States
- Founded
- 2006
- Employees
- 23
- Website
- mauiimaging.com/
- Ownership
- Privately Held (backing)
Maui Imaging doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Maui Imaging shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Maui Imaging in its N-PORT filings yet. We sweep new filings monthly.